|
EGFL8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.800000E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.815700E-04 |
| Normal-vs-Stage2 |
8.106200E-02 |
| Normal-vs-Stage3 |
8.294400E-01 |
| Normal-vs-Stage4 |
6.477600E-01 |
| Stage1-vs-Stage2 |
7.497600E-01 |
| Stage1-vs-Stage3 |
2.497200E-03 |
| Stage1-vs-Stage4 |
3.793600E-02 |
| Stage2-vs-Stage3 |
1.154830E-01 |
| Stage2-vs-Stage4 |
2.979000E-01 |
| Stage3-vs-Stage4 |
7.913200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.981400E-04 |
| Normal-vs-AfricanAmerican |
1.544120E-02 |
| Normal-vs-Asian |
2.883000E-01 |
| Caucasian-vs-AfricanAmerican |
3.727800E-01 |
| Caucasian-vs-Asian |
6.785200E-01 |
| AfricanAmerican-vs-Asian |
8.497400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.00640000000263E-05 |
| Normal-vs-Female |
2.150800E-01 |
| Male-vs-Female |
2.698400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.766300E-02 |
| Normal-vs-Extreme_Weight |
1.175410E-03 |
| Normal-vs-Obese |
8.043600E-03 |
| Normal-vs-Extreme_Obese |
9.804400E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.868200E-01 |
| Normal_Weight-vs-Obese |
8.779200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.089600E-01 |
| Extreme_Weight-vs-Obese |
6.570400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.545200E-01 |
| Obese-vs-Extreme_Obese |
8.222600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.120600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.658360E-03 |
| Normal-vs-Age(61-80Yrs) |
3.364000E-04 |
| Normal-vs-Age(81-100Yrs) |
7.764600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.830600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.097800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.805600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.572600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.730000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.470390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.20230000399957E-08 |
| Normal-VS-Type2 PRCC |
1.320840E-01 |
| Normal-VS-KIRP CIMP |
3.417600E-01 |
| Normal-VS-Unclassified PRCC |
1.885960E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.62436730732907E-12 |
| Type1 PRCC-VS-KIRP CIMP |
1.68949999546086E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
1.45579999999423E-06 |
| Type2 PRCC-VS-KIRP CIMP |
9.331000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.516620E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.430000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.038500E-02 |
| Normal-vs-N1 |
8.923000E-01 |
| Normal-vs-N2 |
3.465400E-01 |
| N0-vs-N1 |
1.763980E-02 |
| N0-vs-N2 |
4.830400E-04 |
| N1-vs-N2 |
2.257600E-01 |
|
|
